Sort by
Refine Your Search
-
inhouse developed long-acting GLP-1 receptor agonist, Efsubaglutide alfa , has achieved regulatory approval and market access in China representing a major milestone in biologics innovation originating from
Enter an email to receive alerts for Design-"https:"-"https:" positions